Kristyanto H, Rey Torre S, Cunney A, Dunder K, et al. The European Medicines Agency evaluation of nemolizumab (Nemluvio) for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis. Br J Dermatol 2025 Jun 28:ljaf259. doi: 10.1093.
PMID: 40580139